The popularity of these drugs has led to a sea of GLP-1 offerings flooding the marketnot all of them FDA-approved
Monitoring Strategy Baseline (before starting): Complete pain assessment with validated tools Neurological examination Basic metabolic panel, HbA1c (if diabetic), vitamin B12, TSH INR if on warfarin Cardiovascular risk assessment Ongoing: Pain assessment every 4-8 weeks initially, then every 12 weeks INR weekly 2 weeks then monthly if on warfarin Neurological examination every 6-12 months Annual laboratory monitoring for long-term use 4
It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
However, like any cosmetic or wellness treatment, they come with certain risks and precautions
At 8-12 weeks is when the long-term cognitive and mood-stabilizing effects take hold, along with the less outwardly expressed benefits of the peptide (i.e., reduced inflammation, improved immune function, and neuroprotection)